Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 115 clinical trials
Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal (BOVARY CE)

BOVARY-CE is a monocentric, pilot, longitudinal, real-life study with a total duration of 36 months. The purpose of this study is to assess the feasibility of using liquid biopsy as a substitute

cancer of the ovary
fallopian tube
carcinoma
  • 0 views
  • 18 Apr, 2022
  • 1 location
Circulating Extracellular Exosomal Small RNA as Potential Biomarker for Human Pancreatic Cancer

This study is for the verification of biomarkers for pancreatic cancer treatment using small RNA liquid biopsy, combined with EUS-FNA tissues.

  • 0 views
  • 26 Jan, 2021
  • 1 location
Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma (ExTRACT-HCC)

This prospective clinical trial will evaluate PET/CT and genomic liquid biopsy based biomarkers as predictors of clinical therapeutic response to immune-checkpoint inhibitor (ICI) therapy for

  • 0 views
  • 25 Apr, 2022
  • 1 location
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

The purpose of the study is to evaluate the use of a circulating tumor DNA (ctDNA) assay, ie, a "liquid biopsy," as a tool to identify triple-negative breast cancer (TNBC) patients who will or

progesterone
estrogen
mammogram
capecitabine
  • 0 views
  • 21 Mar, 2022
  • 1 location
EUS Guided HVA and PVA for Circulating Tumor DNA in Patients

The discovery of cell-free circulating tumor DNA (crDNA) in blood and the maturation of technologies for ctDNA analysis have presented an attractive opportunity for minimally invasive "liquid

  • 0 views
  • 15 Mar, 2021
  • 1 location
Tolerability and Efficacy of UV1 Vaccine in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for First-line Treatment With Pembrolizumab

, this study will explore patient subgroups most likely deriving benefit from a targeted immunotherapy approach combining a checkpoint inhibitor with a cancer vaccine and help to establish liquid biopsy

  • 0 views
  • 19 Oct, 2021
  • 1 location
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine

clinical samples and data from lung cancer patients, will be used to elucidate genomic background metrics, identify cell free DNA mutations, and further refine the liquid biopsy approach. Blood and urine

solid tumor
Accepts healthy volunteers
lung cancer
lung carcinoma
cancer
  • 3 views
  • 24 Feb, 2022
  • 1 location
Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Carcinoma

to evaluate and describe similarities and differences between the treatment suggestions based on CGP/IHC (immuno-histochemistry) of tissue biopsy and liquid biopsy. In patients

carcinoma
  • 0 views
  • 06 Dec, 2021
  • 1 location
Liquid Biopsies and IMAging for Improved Cancer Care

The recently developed liquid biopsy technology (to obtain and characterize tumour cells and tumour components like Deoxyribonucleic acid (DNA) or Ribonucleic Acid (RNA) from a simple blood draw

adenocarcinoma
measurable disease
renal function
  • 0 views
  • 27 Jun, 2021
  • 1 location
Detection of Viable CTCs Using the EPIDROP Technology in Metastatic Prostate Cancer (EPIDROP)

The use of liquid biopsy could be the key for precision medicine. Circulating tumor cells (CTCs) are the most studied circulating biomarkers used to assess the metastatic process and they have

  • 0 views
  • 09 Jun, 2021
  • 2 locations